Desempeño ASG en el sector farmacéutico y de biotecnología en 2024

Please fill out the form
to download the file

Este informe ofrece un análisis detallado de los resultados en materia de sostenibilidad de 86 compañías europeas del sector Farmacéutico y de Biotecnología, basado en la evaluación de ESG Ratings de EthiFinance realizada en 2024 con datos correspondientes al ejercicio fiscal 2023. El estudio destaca las principales tendencias y conclusiones sobre los aspectos más importantes del sector en los cuatro pilares de sostenibilidad: Medioambiental, Social, Gobernanza y Grupos de Interés Externos; y ofrece información sobre los avances y los retos del sector en materia de prácticas sostenibles. 

Promoting informed & responsible decision-making for a more sustainable finance and economy

ESG Rating Agency

Helping investors to make informed and responsible decisions

Learn More
Credit Rating Agency

Helping companies to ensure transparency and facilitate their access to finance

Learn More
Get in Touch

Your information is used solely by EthiFinance to manage your request and/or complaints raised before it for which you are giving your explicit consent. Mandatory fields are marked with an asterisk; your request may not be addressed in the absence of such information. We inform you that you may exercise your rights of access, rectification, erasure, object, portability, restriction in processing and to be forgotten by contacting our Group DPO at the following address: dpo@ethifinance.com. For more information on the processing of your personal data by EthiFinance, please refer to our privacy policy available on our website at the following address: Privacy Policy